Patents by Inventor Jorgen NELSON

Jorgen NELSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230340071
    Abstract: The present invention is related to, inter alia, de novo IL-2R13 binding polypeptides.
    Type: Application
    Filed: March 12, 2021
    Publication date: October 26, 2023
    Applicants: Neoleukin Therapeutics, Inc., University of Washington
    Inventors: Daniel Adriano Silva Manzano, Alfredo Quijano Rubio, Jesus Renan Vergara Gutierrez, Thomas Linsky, Jorgen Nelson
  • Patent number: 9771395
    Abstract: Designed polypeptides having the amino acid sequence of SEQ ID NQ: 1 are described that bind with high affinity and selectivity to the influenza hemagglutinin protein, and which can be used for treating and/or limiting an influenza infection, as well as diagnosing an influenza infection and identifying candidate compounds for treating an influenza infection.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: September 26, 2017
    Assignee: University of Washington
    Inventors: Merika Treants Koday, Deborah L. Fuller, Aaron Chevalier, Jorgen Nelson, David Baker
  • Publication number: 20170073375
    Abstract: Designed polypeptides having the amino acid sequence of SEQ ID NQ: 1 are described that bind with high affinity and selectivity to the influenza hemagglutinin protein, and which can be used for treating and/or limiting an influenza infection, as well as diagnosing an influenza infection and identifying candidate compounds for treating an influenza infection.
    Type: Application
    Filed: March 20, 2015
    Publication date: March 16, 2017
    Inventors: Merika Treants KODAY, Deborah L. FULLER, Aaron CHEVALIER, Jorgen NELSON, David BAKER